Company profile: Polymateria
1.1 - Company Overview
Company description
- Provider of Biotransformation technology enabling full biodegradation of common plastics, leaving zero microplastics and no environmental harm, including Lyfecycle plastics that safely biodegrade within a year if not recycled, leaving no harmful residues. Offers bespoke masterbatch formulations compatible with normal conversion processes, and biodegradable products such as stretch film, shrink wrap, and toilet paper bags.
Products and services
- Bespoke Masterbatch: Custom-engineered formulations tailored to the plastic’s use life and application, compatible with normal plastic conversion processes for seamless incorporation into existing production
- Biotransformation technology: Industrial-grade system enabling common plastics that escape refuse streams to fully biodegrade in the natural environment, leaving zero microplastics and causing no environmental harm
- Lyfecycle: Commercial-grade plastic technology engineered to biodegrade safely back to nature within a year if not recycled, leaving no harmful residues after breakdown
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Polymateria
Periodic Products
HQ: United States
Website
- Description: Provider of material science technology focused on enhancing the commercial potential of unique, versatile, biodegradable polymer compounds and metallopolymer composite materials. An online inquiry form is available on the company's website.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Periodic Products company profile →
Kromek
HQ: United Kingdom
Website
- Description: Provider of patented radiation detection technologies for medical imaging, nuclear detection, and security screening, including wearable gamma/neutron PRDs and RIIDs, networked detection systems, drone-based radiological mapping, and fixed static nodes. Pioneering digital colour x-ray imaging and advanced 3D imaging with ground-breaking materials technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kromek company profile →
Gratomic
HQ: Canada
Website
- Description: Provider of low-cost, carbon-neutral vein graphite, focused on mining and exploration, upscaling naturally pure vein graphite to 99%+ Cg battery grade through the addition of air classification, targeting EV and energy storage supply chains.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gratomic company profile →
Arsenal Medical
HQ: United States
Website
- Description: Provider of biomaterial-based medical solutions leveraging proprietary therapeutic foam and AxioCore high-throughput nanofiber technology platforms to improve local therapy for injury and disease, including ResQFoam to control abdominal hemorrhage and provide time to reach surgery, and NeoCast, an injectable that deeply penetrates blood vessels to achieve complete vascular occlusion in neurovascular interventions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arsenal Medical company profile →
Cambrios
HQ: United States
Website
- Description: Provider of electronic materials for the display industry, offering wet-processable transparent conductive films and nanostructured materials that can be deposited using existing production equipment to enhance the performance of display devices and components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrios company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Polymateria
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Polymateria
2.2 - Growth funds investing in similar companies to Polymateria
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Polymateria
4.2 - Public trading comparable groups for Polymateria
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →